Log in

NYSEARCA:VCITVanguard Intermediate-Term Corporate Bond ETF Stock Price, Forecast & News

+0.15 (+0.16 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $95.27
50-Day Range
MA: $93.66
52-Week Range
Now: $95.27
Volume2.77 million shs
Average Volume4.10 million shs
Market Capitalization$36.27 billion
P/E RatioN/A
Dividend Yield2.74%

Geographic Exposure of VCIT

Currency Exposure of VCIT

Sector Exposure of VCIT

Industry Exposure of VCIT

Basic Details

Issuer Vanguard
Fund NameVanguard Intermediate-Term Corporate Bond ETF
Tax ClassificationRegulated Investment Company
Inception Date11/19/2009
Fund ManagerJoshua C. Barrickman

Fund Focus

Asset ClassFixed Income
BenchmarkBarclays US 5-10 Year Corp Index
FocusInvestment Grade
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$36.42 billion
Average Daily Volume$6.21 million

ETF Expenses

Management Fee0.06%
Other Expenses0.01%
Total Expenses0.07%
Fee Waiver0.00%
Net Expenses0.07%

Administrator, Advisor and Custodian

AdministratorThe Vanguard Group, Inc.
AdvisorThe Vanguard Group, Inc.
CustodianJPMorgan Chase Bank, N.A.
DistributorVanguard Marketing Corporation
Transfer AgentThe Vanguard Group, Inc.
Lead Market MakerSusquehanna

Receive VCIT News and Ratings via Email

Sign-up to receive the latest news and ratings for VCIT and its competitors with MarketBeat's FREE daily newsletter.

Vanguard Intermediate-Term Corporate Bond ETF (NYSEARCA:VCIT) Frequently Asked Questions

How has Vanguard Intermediate-Term Corporate Bond ETF's stock been impacted by COVID-19 (Coronavirus)?

Vanguard Intermediate-Term Corporate Bond ETF's stock was trading at $89.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VCIT shares have increased by 6.4% and is now trading at $95.27. View which stocks have been most impacted by Coronavirus.

Has Vanguard Intermediate-Term Corporate Bond ETF been receiving favorable news coverage?

News coverage about VCIT stock has trended negative this week, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Vanguard Intermediate-Term Corporate Bond ETF earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an effect on the stock's share price in the next several days. View the latest news about Vanguard Intermediate-Term Corporate Bond ETF.

What other stocks do shareholders of Vanguard Intermediate-Term Corporate Bond ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vanguard Intermediate-Term Corporate Bond ETF investors own include Exxon Mobil (XOM), AbbVie (ABBV), BP (BP), Dell (DELL), Walt Disney (DIS), Ford Motor (F), Freeport-McMoRan (FCX), General Electric (GE), Gilead Sciences (GILD) and SPDR Gold Shares (GLD).

What is Vanguard Intermediate-Term Corporate Bond ETF's stock symbol?

Vanguard Intermediate-Term Corporate Bond ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "VCIT."

How do I buy shares of Vanguard Intermediate-Term Corporate Bond ETF?

Shares of VCIT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vanguard Intermediate-Term Corporate Bond ETF's stock price today?

One share of VCIT stock can currently be purchased for approximately $95.27.

How big of a company is Vanguard Intermediate-Term Corporate Bond ETF?

Vanguard Intermediate-Term Corporate Bond ETF has a market capitalization of $36.27 billion.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.